Zoetis Horses — Revenue decreased by 98.8% to $76.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 16.9%, from $65.00M to $76.00M. Over 4 years (FY 2021 to FY 2025), Horses — Revenue shows an upward trend with a 9.2% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
An increase indicates growing market penetration or higher demand for equine health products, while a decrease may signal competitive pressure or a contraction in the equine care market.
This metric represents the total gross sales generated from products specifically designed for the equine health market,...
Comparable to equine-specific revenue segments in other animal health or veterinary pharmaceutical companies.
zts_segment_horses_revenue| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $68.00M | $60.00M | $4.24B | $64.00M | $63.00M | $58.00M | $4.75B | $72.00M | $65.00M | $60.00M | $5.09B | $66.00M | $68.00M | $58.00M | $5.80B | $65.00M | $72.00M | $66.00M | $6.08B | $76.00M |
| QoQ Change | — | -11.8% | >999% | -98.5% | -1.6% | -7.9% | >999% | -98.5% | -9.7% | -7.7% | >999% | -98.7% | +3.0% | -14.7% | >999% | -98.9% | +10.8% | -8.3% | >999% | -98.8% |
| YoY Change | — | — | — | — | -7.4% | -3.3% | +12.2% | +12.5% | +3.2% | +3.4% | +7.2% | -8.3% | +4.6% | -3.3% | +13.9% | -1.5% | +5.9% | +13.8% | +4.8% | +16.9% |